Correlation between particle size, in vivo particle persistence, and lung injury. by Oberdörster, G et al.
Correlation between Particle Size, In Vivo
Particle Persistence, and Lung Injury
Gunter Oberdorster,1 Juraj Ferin,1 and Bruce E. Lehnert2
'University of Rochester, Department of Environmental Medicine, Rochester, New York; 2Los Alamos National
Laboratory, Life Sciences Division, Los Alamos, New Mexico
Dosimetry parameters such as deposition, clearance, retention, and translocation and dissolution of inhaled particles in and to different lung com-
partments may be important for the persistence of particles in the lung and may correlate with adverse pulmonary effects. We investigated such
correlations using a model involving TiO2 particles of two particle sizes (20 nm diameter, ultrafine; 250 nm diameter, fine) of the same crystalline
structure (anatase). A 12-week inhalation experiment in rats resulted in a similar mass deposition of the two particle types in the lower respiratory
tract. The ultrafine particles elicited a persistently high inflammatory reaction in the lungs of the animals compared to the larger-sized particles. In the
postexposure period (up to 1 year) retention in the alveolar space per se was not different between fine and ultrafine TiO2. However, the following
differences between the particle types were noted: a significantly different total pulmonary retention, both quantitatively (significantly prolonged
retention of the ultrafine TiO2) and qualitatively (increased translocation to the pulmonary interstitium and persistence there of the ultrafine TiO2);
greater epithelial effects (Type II cell proliferation; occlusion of pores of Kohn) and the beginning of interstitial fibrotic foci with ultrafine TiO2; signifi-
cant sustained impairment of alveolar macrophage function after ultrafine TiO2 exposure as measured by the clearance of test particles. A correla-
tion between particle surface area and effects was observed. A comparison of the adverse reactions with dosimetric parameters of TiO2 in different
lung compartments in the postexposure period showed a correlation of the persistence of effects in both the alveolar and interstitial space with the
persistence of particles in the respective compartment. - Environ Health Perspect 102(Suppl 5):173-179 (1994)
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Introduction
When evaluating exposure-dose-effect
relationships ofinhaled particles the defini-
tion and determination ofthe relevant dose
is crucial (Figure 1). The initially deposited
dose may not be a decisive parameter, since
particles probably clear at varying rates
from different lung compartments. In con-
trast, the retained dose may be the more
important parameter. Conventionally and
conveniently, doses usually are expressed in
terms of particle mass (gravimetric dose).
However, when different types ofparticles
are compared, doses may be more appro-
priately expressed as particle volume, parti-
cle surface area, or numbers of particles,
depending on the effect in question. For
example, the retardation of alveolar
macrophage-mediated clearance due to par-
ticle overload appears to be better corre-
lated with phagocytized particle volume
rather than mass ( ).
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Figure 1. Biopersistence and biodurability in relation to dose parameters for exposure-dose-effect relationships of
inhaled nonfibrous andfibrous particles.
The retained dose is a result of the should be reserved for chemical processes
biopersistence of a particulate compound,
which is based on several clearance mecha-
nisms. These can summarily be described
by physical/mechanical and chemical
processes. Although the terms retention,
biopersistence, and biodurability often are
used interchangeably, we suggest that
"biopersistence" should refer to the in vivo
behavior of a particle (fibrous or nonfi-
brous) and that "retention" should reflect a
dosimetric term. The term "biodurability"
occuring in vivo and contributing to biop-
ersistence. Biopersistence mechanisms can
be very different for different pulmonary
compartments (e.g., alveolar vs interstitial,
intracellular vs extracellular). The issue of
biopersistence and the correlation between
particle dose parameters and retention in
individual lung compartments have been
studied here by performing inhalation
studies with TiO2 particles oftwo sizes and
evaluating resulting specific effects. Both
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particle types were TiO2 of submicronic
particle size with the crystalline structure of
anatase, one particle type with an average
particle diameter of about 20 nm (ultra-
fine) and the other with an average diame-
ter ofabout 250 nm (fine). Both are highly
insoluble, so their biopersistence is mainly
due to physical/mechanical processes. This
study was based in part on our previous
observation that the intratracheal instilla-
tion of ultrafine particles led to a signifi-
cantly greater pulmonary inflammatory
response than larger-sized particles (2,3).
Methods
Male Fischer 344 rats (bw 177 g ± 12 g)
were exposed in whole body exposure
chambers to either ultrafine TiO2 (TiO2 -
D) at a concentration of 23.5 ± 2.9 mg/m3
or fine TiO2 (TiO2-F), at 22.3 ± 4.2
mg/m3. The exposure was for 6 hr/day, 5
days/week for 12 weeks; there were 64 ani-
mals per group. Control animals were
sham-exposed to filtered air. Upon
aerosolization, both TiO2 particle types
formed agglomerates with mass median
aerodynamic diameters of 0.71 lpm (TiO2-
D) and 0.78 pm (TiO2-F) and with geo-
metric standard deviations of 1.9 for
TiO2-D and 1.7 for TiO2-F. Since the aero-
dynamic diameters of the aerosols were
essentially the same for the two particle
types, the compartmental deposition in the
respiratory tract ofthe animals was expected
to be very similar. After deposition in the
lung these particle agglomerates appear to
disaggregate to smaller aggregates, as we
and others (4) have observed by electron
microscopy oflung sections. At 4, 8, and 12
weeks of the exposures, six animals per
group were killed by an overdose of pento-
barbital. Further animals were killed at 29
and 64 weeks after cessation ofexposure.
The following measurements during and
after exposure were performed: analysis of
TiO2 burdens in different compartments of
the lung, i.e., lavagable versus nonlavagable
particle burdens, and particle content in
regional lymph nodes. An extensive lung
lavage was performed, and lavagable cells
were analyzed for macrophages, polymor-
phonuclear cells (PMNs), lymphocytes, and
other types. Furthermore, lysosomal and
cytosolic enzymes and total protein were
determined in the lavage fluid, as additional
parameters of toxicity. Light and electron
microscopy were performed after respective
preparation of fixed lung sections to evalu-
ate epithelial and interstitial responses.
An important parameter of alveolar
macrophage (AM) function, i.e., AM-
mediated particle clearance, was deter-
Table 1. Lavagability of polystyrene particlesfrom rat lungs byextensive lavage.
Dayafter 3.5-pm particles 10.3-pm particles
administration % lavagable % nonlavagable % lavagable % nonlavagable
4
10
30
62
132
202
80
80
79
75
75
77
76
20
20
21
25
25
23
24
86
85
83
80
80
78
76
14
15
17
20
20
22
24
With inflammation (20-40% PMN)
1 81 19
1 78 22
1 76 24
Radioactively labeled polystyrene particles of two sizes were administered by intratracheal instillation to differentiate
between alveolar lung burden, interstitial lung burden, andtotal lung burden. Interstitial dose =total lung burden -alveo-
lar burden - lymph node burden. (Particle dose 20-100 pg(. On average, 23% of alveolar burden was nonlavagable after
day 30. (Alveolar burden = 1.3 x lavagable amount(. This number was not influenced by inflammation induced by coin-
stilling ultrafineTiO2togetherwith the polystyrene particles.
mined by measuring in vivo the retention
kinetics of 85Sr-labeled polystyrene test
particles (3M Company) following inhala-
tion via tracheal tubes. For this purpose,
four rats of each group were anesthetized
with halothane after 12 weeks of exposure
(end ofexposure) and another four rats per
group after 7 months, and connected to a
respirator system by intratracheal tubes
(inserted via the mouth), which allowed
groups of up to 16 rats to be exposed to the
test particles simultaneously without any
external fur contamination. An aerosol of
the labeled particles was inhaled over a
period of 15 min. The retained activity of
85Sr was determined on subsequent days
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(up to 200 days postexposure) by a double
detector system collimated to the lung
region of the rats. Short- and long-term
effective clearance rates were determined
from the data and the respective biological
retention halftimes were calculated.
Results of these measurements were
correlated with specific doses of the
retained particles in individual lung com-
partments. To assess the burden ofparticles
in the alveolar space versus the interstitium,
the excised lungs of the animals were
lavaged extensively 10 times with a volume
of 5.0 ml saline per wash cycle. This
yielded an average of approximately
1.1 to 1.2 x 107 total cells in the lung
1000 ~Lymph Nodes
(Om)
200; I/ O @o _ *0(250 nm)
0~~~~~~~~
0 100 200 300 400
Days
('4
0
o Et
uu zuu sDuu 4UU
Days
0 100 200 300 400
Days
Figure2.TiO2 burdens in different lung compartments during and after 12 weeks of exposure of rats tofine and ultrafine
TiO2particles(mean ± SD; n=4).
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Figure3. Estimated interstitial burden (left)and interstitial plus regional lymph node burden(right)during and afterexposure ofratsto ultrafine (TiO2-D)andfine(TiO2-F)particles.
washes. However, even an "extensive"
lavage cannot completely deplete the alveo-
lar space ofmacrophages and particles, and
it cannot be assumed that the lavagable
portion is equivalent to the retained dose in
the alveolar space. To determine the alveo-
lar as well as the interstitial dose more
accurately, a pilot study was performed
with instillation of very large (10.3 pm)
and smaller (3.5 pm) polystyrene test parti-
cles labeled with two radioactive tracers
('4'Ce, 95Nb). Groups of animals were
lavaged during the subsequent 202 days
and the lavagable and nonlavagable por-
tions ofthe radioactively labeled test parti-
cles were determined (5). It was assumed
that the larger particles would not be
transferred to the interstitium and that,
accordingly, the sum of lavagable and
nonlavagable fractions would represent the
burden in the alveolar space. Histological
evaluations confirmed that none of the
large test particles were in epithelial cells or
the interstitium, whereas a very few of the
smaller (3.5 pm) particles could occasion-
ally be seen at those sites. On average,
beyond day 30 after instillation, 22.9 ± 2.0
percent of the total retained lung burden
was not lavagable (Table 1). Thus, the alve-
olar burden can be estimated from the
lavagable fraction by multiplying this frac-
tion by 1.3. Furthermore, the interstitial
dose of other retained particulate material
can be calculated by subtracting the alveo-
lar burden and the lymph nodal burden
from the total lung burden.*
To demonstrate that these very differ-
ent polystyrene particles are an accurate
model of TiO2 interaction with AM, 500
pg TiO2-F were coinstilled with the poly-
styrene particles; we found that, both
shortly after instillation and 24 hr later,
there was no difference in the lavagable and
nonlavagable fraction of TiO2 and poly-
styrene particles. Furthermore, since a high
inflammatory response expected with the
ultrafine TiO2 might affect the lavagability
ofthe lung, we also determined the lavaga-
bility of radioactively labeled test particles
in the presence of such inflammation by
coinstilling 500 and 1000 pg ultrafine
TiO2 with radioactive polystyrene particles.
The nonlavagable fraction of the poly-
styrene particles was essentially the same as
before, i.e., approximately 22%, demon-
strating that the inflammatory response did
not influence alveolar lavagability. In con-
trast, a larger fraction ofthe ultrafine TiO2,
compared to the polystyrene particles, was
nonlavagable, indicating some transloca-
tion ofthe ultrafine TiO2 to epithelial and
interstitial sites. We conclude from this
pilot study that for subsequent determina-
tions ofthe alveolar and interstitial burdens
ofparticles, a nonlavagable fraction of23%
(using our lavage technique) ofthe alveolar
burden in rat lungs should be assumed
(Table 1).
Results
Dosimetry
The total retained lung burden at the end
of the 12-week exposure was 6.62 ± 1.22
mg for TiO2-F and 5.22 ± 0.75 mg for
TiO2-D (Figure 2). Assuming first-order
clearance kinetics, retention halftimes for
the ultrafine particles were approximately
500 days and for the larger-sized particles
approximately 170 days postexposure. The
lavagable amount (lavage pellet) postexpo-
sure was generally similar in both particle
groups, indicating no large differences in
the overall clearance of the different parti-
cle sizes from the alveolar compartment.
However, large differences were observed
in the fraction remaining in the lung. The
ultrafine TiO2 particles showed a signifi-
cantly greater fraction being retained com-
pared to the fine TiO2 particles. A
significantly larger fraction ofthe ultrafine
particles was transferred to the regional
lymph nodes, as compared with fine parti-
cles, indicating a greater ability of the
ultrafine particles to enter interstitial spaces
after alveolar deposition (Figure 2).
The interstitial dose of the retained
TiO2 particles was determined (see
Methods). More than 50% of the total
retained lung burden ofthe ultrafine parti-
cles could be attributed to interstitial local-
ization at the two postexposure time points
studied (Figure 3). For the fine particles,
this was also the case at the latest time
point examined. The interstitial dose
decreased somewhat beyond week 41 for
the ultrafine particles, whereas it continued
to increase for the fine particles. This may
indicate a faster clearance rate ofthe ultra-
fine particles from interstitial sites as
opposed to the fine particles, perhaps, via
the bronchus-associated lymphatic tissue
(BALT) onto the mucociliary escalator of
the conducting airways (6). This, however,
needs to be investigated further.
The clearance of both TiO2 particle
types from the alveolar space showed simi-
lar kinetics as indicated in Figure 2 (lavage
pellet). A more complete analysis of the
data is given in Table 2 by comparing the
amounts ofTiO2 in the alveolar and inter-
stitial spaces 1 year after the end of expo-
sure. In spite of the prolonged pulmonary
retention of ultrafine TiO2 (Figure 2), the
overall clearance of both particle types
from the alveolar space is virtually identi-
cal. Within the 1-year period postexposure,
93% of either particle type present at
the end of exposure in the alveolar space
was removed from this compartment.
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Table2 Clearance ofTiO2 particlesfrom alveolarspace during 1 yearaftercessation of 12-weekexposure.
Interstitial space
Alveolarspace (incl. LN)
Time after Clearance Input Clearance to othersites(GI)
exposure days pg pg % pg pg % (ofAlveolar) %(ofalveolar)
0 4192 1023
3915 93
365 277 2864
0 6202 412
365 459
5743 93
1200
However, clearance pathways for the two
TiO2 particles evidently differed markedly.
A large fraction (44%) of alveolar burden
of the ultrafine particles appeared in the
interstitial space, compared to only 13%
for the fine particles. Most ofthe fine par-
ticles presumably cleared to the GI tract,
although fecal excretion of TiO2 particles
was not specifically evaluated in the present
study. Clearance to the GI tract was much
less for the ultrafine particles, indicating
prolonged clearance of these particles from
1841 44
788 13
50
80
the alveolar space via AM and up the
mucociliary escalator.
IneflammatoryResponse
There was a progressive increase in total
cells lavaged from the TiO2-D exposed ani-
mals during the 12-week exposure period
(Figure 4), due to an increase ofboth AM
and PMNs. The inflammatory response to
the TiO2-D persisted for a long period after
exposure. The numbers of these cell types
had returned almost to normal levels 1 year
after exposure. These effects were not (or
only modestly) observed with TiO2-F. The
lavagable protein (Figure 4), (as well as
cytoplasmic and lysosomal enzymes-LDH
and P-glucuronidase-data not shown),
was also significantly elevated in the lavage
fluid from animals exposed to the ultrafine
particles during and at the end ofthe expo-
sure and at week 41 after the start ofexpo-
sure. Taken together, these data show the
greater pulmonary inflammatory potency
of inhaled ultrafine TiO2 particles com-
pared to fine TiO2 particles, when
lung doses are expressed in terms ofparticle
mass (equal gravimetric doses). This con-
firms earlier results obtained with intratra-
cheally instilled ultrafine and fine TiO2
particles (3).
However, when the inflammatory
influx of PMNs was correlated with the
surface area of the retained particles (i.e.,
lavagable particles) both ultrafine and fine
particle effects could be described by a
common dose-effect curve. This underlines
the importance of considering different
dose parameters (e.g., mass vs surface area)
when interpreting particle effects. These
results also confirmed earlier findings with
instilled particles (3).
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Figure 4. Lung lavage parametersduring and after 12weeks of exposure of rats toTiO2-D (ultrafine) andTiO2-F(fine) particles compared to sham exposed controls(mean ± SD; n =8).
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Figure 5. Pulmonary clearance rates of 'Sr labeled test
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dence interval; a =significantly different from control; b=
significantlydifferentfrom TiO2-F).
AlveolarMacrophag Clearance
Function
Subchronic inhalation ofultrafine and fine
TiO2 particles resulted in a significant
impairment of AM-mediated test particle
clearance (Figure 5). Control animals had a
clearance rate of the test particles of
approximately 1% per day, for the animals
exposed to the fine particles, the clearance
rate was reduced to 0.6% per day; and for
those exposed to the ultrafine particles, it
was even further reduced, to 0.13% per
day. Retention half-times were 66 days for
the control animals, 117 days for those
exposed to fine particles, and 541 days for
those exposed to ultrafine particles. Seven
months after exposure, when the TiO2 bur-
dens in the lung had decreased (Figure 2)
the test particle clearance for animals
exposed to fine particles was no longer
impaired, whereas the animals exposed to
ultrafine particles still showed a signifi-
cantly diminished clearance rate of0.52%.
Since prolonged AM clearance function
in a particle overload situation may be cor-
related with the volumetric burden of the
phagocytized particles in the AM (1), dif-
ferent dose parameters ofthe TiO2 particles
retained in the AM were correlated with
the impaired particle clearance. Neither
average gravimetric nor average volumetric
burdens of both particle types correlate
well with the observed effect on AM clear-
ance function (Table 3). With fine TiO2
particles, there was an AM volumetric load
of 9%, greater than the 6% that Morrow
hypothesized (1) to indicate a particle
overload condition with subsequent effect
on particle clearance; indeed, prolonged
clearance was seen in the present study.
Exposure to ultrafine particles, however,
resulted in much lower average volumetric
burdens, which possibly indicated an
increased cytotoxicity of these particles.
Expressing these doses as the retained
particle surface area in the macrophages
shows that the effects on AM-mediated
clearance function ofthe two different par-
ticle types can be expressed by a common
dose-response curve (Figure 6). (Calcula-
tion of the phagocytized volume is based
on an average rat AM volume of 1000 lim3
[7] and of a TiO2 anatase density of
3.8 g/cm3. The specific surface area had
been determined previously to be 50 m2/g
for ultrafine TiO2 and 6.4 m2/g for fine
TiO2).
LungMorphology
Histological evaluation of lung sections at
41 weeks ofthe study showed early fibrotic
reactions in the ultrafine TiO2-exposed
animals and to a lesser degree also in the
animals exposed to fine TiO2. However, 1
year after the exposure the early fibrotic
reactions had shown signs ofregression and
were no longer as prominent (8). Type II
cell hyperplasia, especially in alveoli that
contained aggregates ofparticle-laden AM,
was also observed in the animals exposed to
ultrafine particles. The observation that
such epithelial response resulted in
the occlusion of the pores of Kohn may
have important implications, since these
pores are thought to serve as interalveolar
migration pathways for AM (9-11).
Interstitial inflammatory reactions, (i.e.,
PMN increases), were also observed to a
higher degree at the end of the exposure
period in the animals exposed to the ultra-
fine particles.
Discussion
This subchronic inhalation study with two
sizes ofTiO2 particles confirmed the previ-
ous findings with these particles after intra-
tracheal instillation. When the same
gravimetric doses of ultrafine and fine
TiO2 particles were delivered to the lung,
ultrafine particles produced significantly
greater inflammation and interstitial
translocation (2,3). The study also shows
that the pulmonary clearance of the ultra-
fine particles was significantly slower, and
that this was due to an altered biopersis-
tence in both the alveolar space and in the
pulmonary interstitium. The overall reten-
tion in the alveolar space was no different
for fine and ultrafine TiO2 particles.
However, compared to the fine TiO2, a
larger fraction of the ultrafine TiO2 was
translocated to the pulmonary interstitium
where it was retained for a longer time.
Dissolution ofTiO2 particles in lung tissue
has not been reported, and we can assume
that pulmonary clearance of these particles
is solely dependent on physical/mechanical
processes (Figure 1).
Several inhalation studies by different
laboratories in the past have shown that a
large load of highly insoluble particles in
the alveolar space results in severe retarda-
tion of AM-mediated particle clearance
(12,13). This phenomenon was referred to
as "particle overload," indicating an over-
loading of the AM by phagocytized parti-
cles with subsequent impairment of their
clearance function. Morrow (1) suggested
that this is correlated with the phagocytized
particle volume and that AM function
starts to be impaired when on average 6%
of the normal AM volume is filled by
phagocytized particles. The load of AM
with fine TiO2 particles in our study did
indeed reach the value of 9% (Table 3),
which was associated with an almost dou-
bling ofthe retention ofinhaled test parti-
cles. However, ultrafine particles only
reached a phagocytized volume in the AM
of 2.6%, yet they prolonged retention of
the test particles by a factor ofmore than 4
(Table 3). Even after 7 months, test parti-
cle clearance continued to be retarded. In
contrast, correlating the prolonged reten-
tion with the retained surface area of the
particles in AM showed that the data could
be expressed with a dose-effect relationship
common to both particle types (Figure 6),
independent ofpostexposure time.
Several points should be emphasized.
One is that the overall retention of both
the fine and ultrafine particles did not dif-
Table3. Particledose parameters and effects onAM-mediated particleclearance.
Retained dose/l0o AM AM-effect
Time
postexposure, nl Particle no. Testparticle retention,
weeks pg (% ofAMvolume) cm2 xl 0- control = 1
Control 0, 29 0 0(0) 0 0 1.0
TiO2.F 0 340 90(9) 21.9 10.9 1.8a
29 32.5 9(0.9) 2.1 1.1 1.1
TiO2-D 0 99.8 26(2.6) 49.9 5420 8.2a
29 43.8 11 (1.1) 21.9 2380 2.0a
AM =alveolarmacrophages.aSignificantchange againstcontrolsp<0.05.
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Figure 6. Correlation between surface area of TiO2 particles phagocytized by AM and pulmonary retention half-time of
inhaled polystyrene testparticles.
fer in the alveolar space (Table 1), although
the ultrafine particles were cleared via the
mucociliary escalator into the GI tract at a
significantly slower rate. This can be
explained by the effect on AM function as
demonstrated by the result ofthe test parti-
cle clearance. A second point is that the
retention in the alveolar space-more pre-
cisely the dose retained in AM expressed as
particle surface area-rather than the over-
all pulmonary retention of the TiO2 parti-
cles, is important for the effect on AM
clearance function. Third, the volumetric
load ofthe AM is not a good predictor for
the delayed clearance effect when ultrafine
particles are involved. The surface area of
the retained particles appears to be a better
dose determinant. Although our data are
limited at this point (four data pairs only,
Figure 6), other studies have also demon-
strated the importance ofthe dose parame-
ter "surface area" for the adverse biological
effects of both fibrous and spherical parti-
cles (14,15). This does not mean that AM
volume load may not be important for AM
clearance function, in particular for larger
particles, as has been shown repeatedly
(5,12,16). However, surface area may
become a significant factor when particle
size gets smaller, apparently gaining greater
importance as dose parameter for particles
in the submicronic range.
The mechanism(s) underlying the
retarded removal ofAM-phagocytized par-
ticles from TiO2-D exposed lungs
remain(s) to be elucidated. Green (9) and
Ferin (10) speculated that the pores of
Kohn may serve as a shortcut bywhich AM
migrate from distal alveoli to more proxi-
mal alveoli, positioned nearer the ciliated
airways, for subsequent transport up the
conducting airways. It is therefore tempt-
ing to speculate that the prolonged AM-
mediated particle clearance observed with
the ultrafine particles was related to the
Type II cell hyperplastic response and
occlusions ofthe pores ofKohn in affected
alveoli. These alveoli often contained large
aggregates of particle-filled AM, which, in
turn, appeared subjectively to contain the
vast bulk ofthe TiO2 present in the alveo-
lar space compartment.
The dose parameter "surface area" of
the particles also correlates better than
other dose parameters with the inflamma-
tory PMN influx into the alveolar space.
This corroborates the earlier results with
instilled particles of several types including
ultrafine and fine TiO2 rutile and anatase,
and with ultrafine carbon black (3). In the
present and earlier studies, the surface area
of the particles retained in the alveolar
space represented a better dose determinant
than surface area ofthe particles retained in
the lung in toto, which underscores the sig-
nificance of determining particulate dose
levels in individual lung compartments.
However, there may also be "interfer-
ence" between lung compartments via
released cellmediators affecting specific
responses, depending on the particle load
in each compartment. For example, the
acute particle-induced inflammatory influx
ofPMN into the alveolar space was signifi-
cantly reduced, when more than 50% ofan
acutely administered high dose ofultrafine
TiO2 particles was rapidly translocated to
the interstitial space, thereby shifting
inflammatory events (e.g., release of
chemotactic factors) to the interstitium.
This reduced PMN influx was not
observed with ultrafine carbon black parti-
cles, which were not rapidly translocated to
the interstitium (3).
The observed early fibrotic reactions in
this study were more pronounced after
TiO2-D exposure than after TiO2-F. This
may also correlate with the larger intersti-
tial dose ofthe ultrafine particles, although
it is conceivable that the particle burden in
the alveolar space also contributed to these
events. It has been clearly demonstrated
that particles, including TiO2, will activate
AM to release both proinflammatory
cytokines and fibrogenic factors (17,18). In
the present study it was observed that
fibroblast growth factors are released in the
alveolar space, partly due to release by AM
(data not shown). Since we could not assess
the fibrogenic activity occurring in the
interstitial space, we cannot differentiate
between the contribution of alveolar and
interstitial burdens to the fibrogenic
response. However, histological evidence
from other studies points to the interstitial
particle load as being most important (19).
We conclude from these studies that
the greater pulmonary effects of ultrafine
particles, compared to larger submicronic
particles, can be explained by their larger
specific surface area, the greater interstitial
access, and their altered biopersistence,
resulting in the increased retention of
ultrafine particles. Pulmonary compart-
mental doses thus should be considered
when evaluating effects (alveolar versus
interstitial versus total dose), and the intra-
pulmonary kinetics and translocation of
particles should be evaluated. We conclude
further that when evaluating the biopersis-
tence and related dose-effect relationships
ofinhaled particles oflargelydifferent sizes,
the particle surface area rather than the
mass ofthe retained particles appears to be
the most relevant dose parameter.
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